TY - JOUR
T1 - Prevalence and Age Distribution of Pemphigus and Pemphigoid Diseases in Germany
AU - Hübner, Franziska
AU - Recke, Andreas
AU - Zillikens, Detlef
AU - Linder, Roland
AU - Schmidt, Enno
PY - 2016/12/1
Y1 - 2016/12/1
N2 - Autoimmune bullous diseases (AIBDs) are characterized by autoantibodies against structural proteins of the epidermis (pemphigus vulgaris and foliaceus) and dermal-epidermal junction (bullous pemphigoid, mucous membrane pemphigoid, pemphigoid gestationis, linear IgA disease, and epidermolysis bullosa acquisita) (Schmidt and Groves, 2016). Clinically, blisters and erosions arise on skin and surface-close mucous membranes. Several reports have estimated the incidence of all AIBDs at between 13.3 and 66 cases per million people per year in Germany, the UK, Switzerland, France, Finland, Italy, and the US, with the highest incidences of bullous pemphigoid occurring in the population older than 80 years of age (150–300 cases/million people/year) and the lowest for epidermolysis bullous acquisita (0.2–0.5 cases/million people/year) (Bertram et al., 2009; Brick et al., 2014; Cozzani et al., 2001; Forsti et al., 2014; Joly et al., 2012; Langan et al., 2008; Marazza et al., 2009; reviewed in Schmidt et al., 2015).
AB - Autoimmune bullous diseases (AIBDs) are characterized by autoantibodies against structural proteins of the epidermis (pemphigus vulgaris and foliaceus) and dermal-epidermal junction (bullous pemphigoid, mucous membrane pemphigoid, pemphigoid gestationis, linear IgA disease, and epidermolysis bullosa acquisita) (Schmidt and Groves, 2016). Clinically, blisters and erosions arise on skin and surface-close mucous membranes. Several reports have estimated the incidence of all AIBDs at between 13.3 and 66 cases per million people per year in Germany, the UK, Switzerland, France, Finland, Italy, and the US, with the highest incidences of bullous pemphigoid occurring in the population older than 80 years of age (150–300 cases/million people/year) and the lowest for epidermolysis bullous acquisita (0.2–0.5 cases/million people/year) (Bertram et al., 2009; Brick et al., 2014; Cozzani et al., 2001; Forsti et al., 2014; Joly et al., 2012; Langan et al., 2008; Marazza et al., 2009; reviewed in Schmidt et al., 2015).
UR - http://www.scopus.com/inward/record.url?scp=84997236724&partnerID=8YFLogxK
U2 - 10.1016/j.jid.2016.07.013
DO - 10.1016/j.jid.2016.07.013
M3 - Journal articles
AN - SCOPUS:84997236724
SN - 0022-202X
VL - 136
SP - 2495
EP - 2498
JO - Journal of Investigative Dermatology
JF - Journal of Investigative Dermatology
IS - 12
ER -